Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...
GlobalData on MSN9h
J&J and Lilly both unveil IL-23 inhibitor efficacy in Crohn’s diseaseAfter both receiving FDA approval in UC, J&J and Eli Lilly are racing for their IL-23 inhibitors to get the green light in ...
Zacks.com on MSN6h
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?Eli Lilly LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for ...
Over the last 3 months, EPS estimates have seen 0 upward revisions and 13 downward. Revenue estimates have seen 16 upward ...
The United States said Monday it was "deeply concerned" about a bill, now passed by Israel's parliament, that bans the UN's Palestinian refugee agency from operating in the country and occupied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback